The most sought-after benefit of this medication is its ability to lower blood sugar levels in a safe manner, meaning without increasing hypoglycemia in the patient, allowing for more control of glucagon levels
(2018) 27:74056.10.1016/j.cmet.2018.03.001 28
The gut-microbiome-metabolism axis seems bidirectional, with GLP-1-producing L-cells reacting to microbial metabolites, especially butyrate and propionate
10.1038/s41580-018-0049-3 63 YostenG
Pharmacological risks : Even if the product is genuine, the adverse effect profile of retatrutide as observed in the published phase 2 clinical trial includes nausea, vomiting, diarrhoea, decreased appetite, and injection-site reactions
Zepbounds dual action may actually improve tolerability for some